» Articles » PMID: 18382099

Serous Cystadenoma of the Pancreas: Clinical and Pathological Features in 33 Patients

Overview
Journal Pancreatology
Date 2008 Apr 3
PMID 18382099
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To report the clinicopathological features of patients with serous cystadenomas of the pancreas.

Methods: Thirty-three cases of serous cystadenoma diagnosed between 1977 and 2006 were retrieved from the files of the Ohio State University Medical Center. Clinical data and microscopic slides were reviewed.

Results: The patients included 27 women and 6 men with an age range of 38-83 (mean 64.3) years. The clinical presentation included 13 patients with abdominal pain and 8 patients with abdominal mass; 9 tumors were found incidentally. Abdominal CT scans in 25 patients were interpreted as suspicious for carcinoma in 8 (32%), suspicious for serous cystadenoma in 8, neoplasm not otherwise specified in 8, and suspicious for a pseudocyst in 1. Only 7 patients underwent a preoperative biopsy, and 5 of these were diagnosed as having a serous cystadenoma. All but 2 of the patients underwent surgical resection of the tumor. The serous cystadenomas varied in size from 1.0 to up to 13 cm in maximum dimension, and all but one had a multicystic appearance. Of the 33 serous cystadenomas, 20 (61%) were located in the pancreatic tail, 4 (12%) in the pancreatic body, 4 in the pancreatic body and tail, and 5 (15%) in the head of the pancreas. Follow-up in 17 patients (median 3 years, range from 1 month to 11 years) showed no recurrence of serous cystadenomas. One patient had von Hippel-Lindau syndrome, 4 patients had diabetes mellitus, 3 patients had metastatic cancer, and 2 patients had ovarian tumors.

Conclusions: Serous cystadenoma is an uncommon neoplasm that can be confused with malignancy both clinically and radiologically; a correct diagnosis is important in order to provide an accurate prognosis.

Citing Articles

Serous Cystadenoma: A Review on Diagnosis and Management.

Ning K, Salamone A, Manos L, Lafaro K, Afghani E J Clin Med. 2023; 12(23).

PMID: 38068358 PMC: 10707442. DOI: 10.3390/jcm12237306.


Pancreatic serous cystoadenoma (CSA) showing increased tracer uptake at 68-GaDOTA-peptide Positron Emission Tomography (68Ga-DOTA-peptide PET-CT): a case report.

Nappo G, Funel N, Giudici S, Spaggiari P, Capretti G, Carrara S BMC Surg. 2020; 20(1):331.

PMID: 33317505 PMC: 7737276. DOI: 10.1186/s12893-020-01004-2.


A case of multiple serous cystadenoma of pancreas.

Sekiguchi N, Nakashima S, Koh M, Ueda M, Tsuda Y, Tanida T Ann Med Surg (Lond). 2020; 60:566-570.

PMID: 33299562 PMC: 7704365. DOI: 10.1016/j.amsu.2020.11.052.


Serous cystadenoma of pancreas: A clinicopathologic experience of 23 cases from a major tertiary care center.

Usman Tariq M, Ahmad Z, Abdul-Ghafar J, Ud Din N Rare Tumors. 2018; 10:2036361318809183.

PMID: 30542522 PMC: 6236590. DOI: 10.1177/2036361318809183.


Benign Tumors and Tumorlike Lesions of the Pancreas.

Basturk O, Askan G Surg Pathol Clin. 2016; 9(4):619-641.

PMID: 27926363 PMC: 5599111. DOI: 10.1016/j.path.2016.05.007.